Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Limula
Lausanne, Vaud, Switzerlandlimula.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Limula has developed a proprietary automated platform—LimONE—for the scalable, closed-system manufacturing of personalized cell and gene therapies. The technology integrates bioreactor and centrifugation steps into a single device to reduce manual labor, contamination risk, infrastructure needs, and costs. It supports both autologous and allogeneic products such as CAR-T cells and gene-edited stem cells. The company collaborates with leading hospitals and biotech firms on pilot studies but does not yet have clinical trial results or commercialized products.
- Therapeutic areas
- Rare DiseasesOncology
- Modalities
- Cell therapies (including CAR-T)Gene-edited hematopoietic stem cellsAutologous and allogeneic cell therapies
- Industry
- Therapeutic Medical Devices
02
Partnerships
Hospitals (San Raffaele Hospital Milan; Institut Paoli-Calmettes Marseille)Process development specialists (Stemmatters Portugal)Biotech companies (Achilles Therapeutics UK)
Beyond the preview
Go deeper on Limula.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Limula.